Gufic Biosciences Ltd (BOM:509079)
₹ 452.15 -3.1 (-0.68%) Market Cap: 45.34 Bil Enterprise Value: 48.66 Bil PE Ratio: 52.03 PB Ratio: 8.51 GF Score: 92/100

Q1 2024 Gufic Biosciences Ltd Earnings Call Transcript

Aug 14, 2023 / 11:00AM GMT
Release Date Price: ₹284.2 (+3.84%)
Operator

Ladies and gentlemen, good day, and welcome to the Q1 FY24 earnings conference call of Gufic Biosciences Limited. This conference call may contain forward-looking statements about the company, which are based on beliefs, opinions, and expectations of the company as on date of this call. These statements are not the guarantees of future performance and involve risks and uncertainties that are difficult to predict.

(Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Ms. Ami Shah, Company Secretary and Compliance Officer of the company. Thank you, and over to you, Ami Shah.

Ami Shah
Gufic Biosciences Limited - Company Secretary & Compliance Officer

Thank you, Melissa. Good afternoon, and a very warm welcome to everyone present on the call. Along with me, I have Mr. Pranav Choksi, CEO and Executive Director; Mr. Devkinandan Roonghta, CFO; and SGA, our Investor Relations advisor.

We have uploaded our results and investor presentation for Q1 '24 on the stock exchange website and on the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot